GRAIL Inc (NAS:GRAL)
$ 68.93 -2.21 (-3.11%) Market Cap: 2.96 Bil Enterprise Value: 2.19 Bil PE Ratio: 0 PB Ratio: 1.13 GF Score: 12/100

Grail Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 03:30AM GMT
Release Date Price: $101.97 (-3.74%)
Henry Jiang
JPMorgan

Good morning. Thank you all for joining us today. My name is Henry Jiang. I'm with the banking team here at JPMorgan, and it's my pleasure to be introducing the Grail team today. Joining me on stage and presenting today will be Bob Ragusa, CEO; and Dr. Josh Ofman, President. Just a quick note, we'll have time for Q&A at the end. And just please wait and we'll get you a microphone if you have any questions.

But with that, I'll pass it over to you, Bob.

Robert Ragusa
Grail Inc - Chief Executive Officer, Director

Thanks, Henry. Appreciate it. So welcome, and thank you for attending this session. I'm Bob Ragusa, Chief Executive Officer at Grail. We're pleased to be here to talk today about the company, the progress we've made as a company and the exciting year ahead. So here are our disclaimers. So today, I will share with you a business review and then Dr. Josh Ofman, who joins me up on stage here, our President, will review Galleri's differentiation and future opportunities.

So we're immensely proud of the progress

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot